89. Lymphangioleiomyomatosis Clinical trials / Disease details


Clinical trials : 39 Drugs : 46 - (DrugBank : 20) / Drug target genes : 27 - Drug target pathways : 137

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04388371
(ClinicalTrials.gov)
October 18, 201911/5/2020Glutamine PET Imaging in LAMGlutamine PET Imaging in LAMLymphangioleiomyomatosis (LAM)Drug: GlutamineVanderbilt University Medical CenterThe LAM FoundationCompleted18 YearsN/AFemale5Phase 1United States